TAF5
Basic information
Region (hg38): 10:103367966-103389065
Previous symbols: [ "TAF2D" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAF5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 1 |
Variants in TAF5
This is a list of pathogenic ClinVar variants found in the TAF5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-103368002-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
10-103368015-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
10-103368204-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
10-103368246-C-T | not specified | Uncertain significance (Dec 13, 2021) | ||
10-103368252-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
10-103368303-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
10-103368366-C-A | not specified | Uncertain significance (May 23, 2024) | ||
10-103368407-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
10-103368417-T-G | not specified | Uncertain significance (Dec 27, 2023) | ||
10-103368426-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
10-103368455-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
10-103368468-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
10-103368539-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
10-103378284-T-A | not specified | Uncertain significance (Nov 29, 2023) | ||
10-103379720-G-A | not provided (-) | |||
10-103379902-G-C | not specified | Uncertain significance (Nov 17, 2023) | ||
10-103381735-G-C | Benign (Dec 04, 2018) | |||
10-103381740-T-A | not specified | Uncertain significance (Jul 20, 2021) | ||
10-103381815-A-G | not specified | Uncertain significance (Aug 02, 2021) | ||
10-103381821-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
10-103381824-G-A | not specified | Uncertain significance (Jul 05, 2022) | ||
10-103383324-G-C | not specified | Uncertain significance (Feb 03, 2022) | ||
10-103383339-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
10-103383340-T-C | not specified | Uncertain significance (Aug 08, 2022) | ||
10-103383361-C-T | not specified | Uncertain significance (Feb 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAF5 | protein_coding | protein_coding | ENST00000369839 | 11 | 21099 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000272 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.65 | 259 | 410 | 0.632 | 0.0000208 | 5133 |
Missense in Polyphen | 43 | 113.86 | 0.37767 | 1419 | ||
Synonymous | 0.638 | 146 | 156 | 0.935 | 0.00000824 | 1607 |
Loss of Function | 5.16 | 3 | 36.7 | 0.0817 | 0.00000213 | 438 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000358 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TAFs components-TIIFD are essential for mediating regulation of RNA polymerase transcription. TAF5/TAFII100 interacts strongly with the histone H4-related TAF6/TAFII80 and the histone H3-related TAF9/TAFII31, as well as a stable complex comprised of both TAF5/TAFII80 and TAF6/TAFII31. Apparently weaker interactions of TAF5/TAFII100 with TBP, TAF1/TAFII250, TAF11/TAFII28, and TAF12/TAFII20, but not TAF7/TAFII55, also have been observed.;
- Pathway
- Basal transcription factors - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Eukaryotic Transcription Initiation;Disease;Gene expression (Transcription);Generic Transcription Pathway;Transcription of the HIV genome;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;RNA Polymerase II HIV Promoter Escape;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;HIV Transcription Initiation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Infectious disease;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.180
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.54
Haploinsufficiency Scores
- pHI
- 0.925
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.641
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.942
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Taf5
- Phenotype
Gene ontology
- Biological process
- chromatin organization;DNA-templated transcription, initiation;regulation of transcription, DNA-templated;transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;viral process;histone acetylation;snRNA transcription by RNA polymerase II;regulation of signal transduction by p53 class mediator
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;transcription factor TFIID complex;nucleolus;actin cytoskeleton;transcription factor TFTC complex
- Molecular function
- DNA-binding transcription factor activity;histone acetyltransferase activity;protein binding;identical protein binding;transcription regulatory region DNA binding;protein dimerization activity